Acquiring Company
Eli Lilly and Company
Acquired Company
Merida Biosciences
IndianapolisCambridgeManufacturingBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsDescription
Eli Lilly and Company has agreed to acquire Merida Biosciences in an all-cash deal potentially worth up to $2.875 billion, contingent on development milestones. This acquisition aims to bolster Eli Lilly's capabilities in the autoimmune and allergy sectors. It is part of Eli Lilly's broader strategy to expand its drug pipeline and maintain its competitive edge. The acquisition is significant for Eli Lilly's long-term growth and innovation efforts.
Don't miss Eli Lilly and Company's next move
Get an email the moment Eli Lilly and Company makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Merida Biosciences?
Merida Biosciences was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on September 7, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire Merida Biosciences?
Eli Lilly and Company's acquisition of Merida Biosciences was reported on September 7, 2026. Eli Lilly and Company has agreed to acquire Merida Biosciences in an all-cash deal potentially worth up to $2.875 billion, contingent on development milestones. This acquisition aims to bolster Eli Lilly's capabilities in the autoimmune and allergy sectors. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Merida Biosciences do?
Merida Biosciences is a biotechnology company based in Cambridge, MA, focused on developing a new class of precision therapeutics. It is privately held, operating in Biotechnology, and is based in Cambridge.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.